Two‐Stage Designs for Gene–Disease Association Studies with Sample Size Constraints
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary Gene–disease association studies based on case–control designs may often be used to identify candidate polymorphisms (markers) conferring disease risk. If a large number of markers are studied, genotyping all markers on all samples is inefficient in resource utilization. Here, we propose an alternative two‐stage method to identify disease‐susceptibility markers. In the first stage all markers are evaluated on a fraction of the available subjects. The most promising markers are then evaluated on the remaining individuals in Stage 2. This approach can be cost effective since markers unlikely to be associated with the disease can be eliminated in the first stage. Using simulations we show that, when the markers are independent and when they are correlated, the two‐stage approach provides a substantial reduction in the total number of marker evaluations for a minimal loss of power. The power of the two‐stage approach is evaluated when a single marker is associated with the disease, and in the presence of multiple disease‐susceptibility markers. As a general guideline, the simulations over a wide range of parametric configurations indicate that evaluating all the markers on 50% of the individuals in Stage 1 and evaluating the most promising 10% of the markers on the remaining individuals in Stage 2 provides near‐optimal power while resulting in a 45% decrease in the total number of marker evaluations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Searching for genetic determinants in the new millennium
Risch, N. J. (2000) · Nature · doi:10.1038/35015718 · Cited by 1,839 · cited 1×
“Alternatively, population-based gene–disease association studies using a large number of polymorphic markers have been proposed as useful methods to identify disease-susceptibility loci (Risch, 2000).”
BackgroundCandidate-gene approaches for studying complex genetic traits: practical considerations
Tabor, H. K., Risch, N. J., & Myers, R. M. (2002) · Nature Reviews Genetics · doi:10.1038/nrg796 · Cited by 1,076
Cited by
Skol, A. D., Scott, L. J., Abecasis, G. R., & Boehnke, M. (2006) · Nature Genetics · doi:10.1038/ng1706 · Cited by 1,286
Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene
Alarcón, M., Abrahams, B. S., Stone, J. L., Duvall, J. A., Perederiy, J. V., Bomar, J. M., Sebat, J., Wigler, M., Martin, C. L., Ledbetter, D. H., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.09.005 · Cited by 818
Sample Size and Statistical Power Calculation in Genetic Association Studies
Hong, E. P., & Park, J. W. (2012) · Genomics & Informatics · doi:10.5808/gi.2012.10.2.117 · Cited by 540
A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization
Arking, D. E., Pfeufer, A., Post, W., Kao, W. H. L., Newton-Cheh, C., Ikeda, M., West, K., Kashuk, C., Akyol, M., Perz, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1790 · Cited by 537
Upward bias in odds ratio estimates from genome‐wide association studies
Garner, C. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20209 · Cited by 103
“…in GWA studies complicates the interpretation of the results, considerable research has gone into developing multistage approaches for validating or replicating statistical results [Lin, 2006; Satagopan and Elston, 2003; Satagopan et al., 2002, 2004; Skol et al., 2006; Thomas et al., 2004].”
Metadata
- Authors
- Satagopan, J. M., Venkatraman, E. S., & Begg, C. B.
- Venue
- Biometrics
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-27
- Volume
- 60
- Issue
- 3
- Pages
- 589-597
- ISSN
- 0006-341X (ISSN-L)
- 1541-0420
- OpenAlex
- W2155221388
- Cited by
- 121
- References
- 2
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Two‐Stage Designs for Gene–Disease Association Studies with Sample Size Constraints. https://app.cochat.ai/papers/10.1111/j.0006-341x.2004.00207.x
- The paper
- Satagopan, J. M., Venkatraman, E. S., & Begg, C. B. (2004). Two‐Stage Designs for Gene–Disease Association Studies with Sample Size Constraints. Biometrics. https://doi.org/10.1111/j.0006-341x.2004.00207.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.